Cargando…
Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine Tumours
SIMPLE SUMMARY: Around two-thirds of patients with small intestinal neuroendocrine tumours are present with a metastatic mesenteric mass. This mass is known to cause intestinal complications, however, little is known on its development over time in the era of targeted therapy. Therefore, we conducte...
Autores principales: | Blažević, Anela, Brabander, Tessa, Zandee, Wouter T., Hofland, Johannes, Franssen, Gaston J. H., van Velthuysen, Marie-Louise F., Feelders, Richard A., De Herder, Wouter W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865677/ https://www.ncbi.nlm.nih.gov/pubmed/33503893 http://dx.doi.org/10.3390/cancers13030443 |
Ejemplares similares
-
Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women
por: Blažević, Anela, et al.
Publicado: (2022) -
Aberrant tryptophan metabolism in stromal cells is associated with mesenteric fibrosis in small intestinal neuroendocrine tumors
por: Blažević, Anela, et al.
Publicado: (2022) -
Peptide Receptor Radionuclide Therapy With (177)Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome
por: Zandee, Wouter T, et al.
Publicado: (2021) -
Effect of epigenetic treatment on SST(2) expression in neuroendocrine tumour patients
por: Refardt, Julie, et al.
Publicado: (2022) -
Epigenetic regulation of SST(2) expression in small intestinal neuroendocrine tumors
por: Klomp, Maria J., et al.
Publicado: (2023)